Literature DB >> 20384944

Urogenital complaints and female sexual dysfunction (part 1).

Salim A Wehbe1, Kristene Whitmore, Susan Kellogg-Spadt.   

Abstract

INTRODUCTION: Sexual dysfunction and dyspareunia are common complaints in women with urological disorders. AIM: To provide a comprehensive review of sexual dysfunction related to common hypersensitive/hyperactive urogenital disorders including interstitial cystitis/painful bladder syndrome (IC/PBS), overactive bladder (OAB) with and without incontinence, and high-tone pelvic floor muscle dysfunction and the appropriate treatment strategies.
METHODS: A medical literature search using several related terms including sexual dysfunction, dyspareunia, IC/PBS, OAB, urinary incontinence pelvic floor dysfunction, and levator ani muscle spasm. MAIN OUTCOME MEASURES: Review of the medical literature to identify relation between sexual dysfunction and common urological disorders in women and to describe appropriate treatment strategies to improve the women's quality of life.
RESULTS: A thorough review of sexual dysfunction in urological disorders and their related treatments modalities including: behavioral, pharmacological, and nonpharmacological therapies.
CONCLUSIONS: Sexual dysfunction is a common, underestimated, and untreated complaint in women with urologic disorders. Identifying sexual complaints and treating the underlying etiologies can result in significant improvement in a woman's quality of life. This process requires a focused, multidisciplinary approach tailored to meet the needs of women with urogenital complaints.

Entities:  

Mesh:

Year:  2010        PMID: 20384944     DOI: 10.1111/j.1743-6109.2010.01769.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  8 in total

1.  Biofeedback versus electrical stimulation for sexual dysfunction: a randomized clinical trial.

Authors:  Behnaz Aalaie; Behroz Tavana; Zahra Rezasoltani; Solmaz Aalaei; Jamshid Ghaderi; Afsaneh Dadarkhah
Journal:  Int Urogynecol J       Date:  2020-06-11       Impact factor: 2.894

2.  A strong pelvic floor is associated with higher rates of sexual activity in women with pelvic floor disorders.

Authors:  Gregg Kanter; Rebecca G Rogers; Rachel N Pauls; Dorothy Kammerer-Doak; Ranee Thakar
Journal:  Int Urogynecol J       Date:  2015-05-21       Impact factor: 2.894

3.  Are clinically recommended pelvic floor muscle relaxation positions really efficient for muscle relaxation?

Authors:  Özge Çeliker Tosun; Damla Korkmaz Dayıcan; İrem Keser; Sefa Kurt; Meriç Yıldırım; Gökhan Tosun
Journal:  Int Urogynecol J       Date:  2022-02-24       Impact factor: 1.932

Review 4.  Urinary disorders and female sexual function.

Authors:  Jaclyn Chen; Genevieve Sweet; Alan Shindel
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

5.  Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial.

Authors:  Catrina C Crisp; Christine M Vaccaro; M Victoria Estanol; Susan H Oakley; Steven D Kleeman; Angela N Fellner; Rachel N Pauls
Journal:  Int Urogynecol J       Date:  2013-05-17       Impact factor: 2.894

6.  Female sexual function following a novel transobturator sling procedure without paraurethral dissection (modified-TOT).

Authors:  Burak Arslan; Ozkan Onuk; Ali Eroglu; Tugrul Cem Gezmis; Memduh Aydin
Journal:  Int Braz J Urol       Date:  2017 Jan-Feb       Impact factor: 1.541

Review 7.  Female Sexual Dysfunctions and Urogynecological Complaints: A Narrative Review.

Authors:  Lavinia Mosca; Gaetano Riemma; Andrea Braga; Matteo Frigerio; Alessandro Ferdinando Ruffolo; Mattia Dominoni; Gaetano Maria Munno; Stefano Uccella; Maurizio Serati; Antonio Raffone; Stefano Salvatore; Marco Torella
Journal:  Medicina (Kaunas)       Date:  2022-07-23       Impact factor: 2.948

8.  How Is the Sexual Function of Premenopausal Chinese Women Without Hyperlipidemia?

Authors:  Yali Xiang; Yuxin Tang; Jiaqun Li; Dongjie Li
Journal:  Sex Med       Date:  2019-12-16       Impact factor: 2.491

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.